Sharechat Logo

VTL - Board announce CEO stands down

Friday 8th April 2022

Text too small?

In response to the company’s FY22 interim result, the Board of Vital Limited (NZX: VTL ) wishes to provide shareholders with an early update related to its ongoing review of the company’s performance.

The Board’s current focus is on Vital’s operational structure to identify and implement sustained cost savings capable of supporting a return to profitability, as early as practicable.

In line with this direction the Board wishes to advise that Vital’s chief executive officer, Andrew Miller, will stand down from his role effective 8 April 2022.

Mr Miller has been working with the Board through this early stage and it has been agreed that the time was right for a change in direction and structure in the role of the CEO going forward.

The Board wishes to acknowledge Mr Miller’s significant contribution to Vital during his five years leading the company.

Jason Bull will be the company’s acting chief executive officer, effective from the date of Mr Miller’s departure, whist the company works to appoint a permanent CEO.

The Board will continue to advise shareholders of all material actions being taken in relation to its performance review process. It also expects to provide a comprehensive overview of the process and actions at the company’s full year results announcement later this year.

ENDS



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report
RAD - Radius Care Announces On-market Share Buyback Programme
MCY - New wind farm propels MCY renewables commitment to $1b